Optimizing mesenchymal stem cell therapy for tendon-bone healing: Multifaceted approaches and future directions
Han Li1, Zhi-Peng Li2,3, Meng-Ting Zhu4
1Department of Orthopedics, Affiliated Dongyang Hospital of Wenzhou Medical University, Jinhua 322100, Zhejiang Province, China.
World Journal of Stem Cells
|January 2, 2026
Summary
Optimizing mesenchymal stem cell (MSC) therapy is crucial for improving tendon-bone healing and reducing re-rupture risk. This review details strategies like preconditioning and biomaterials to enhance MSC effectiveness for better clinical outcomes.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Orthopedic Surgery
Background:
- Tendon-bone healing is a complex process with a high re-rupture rate, posing a significant clinical challenge.
- Mesenchymal stem cells (MSCs) show promise for enhancing tendon-bone healing but face limitations including delivery efficiency, differentiation capacity, and immunogenicity.
- Current research focuses on overcoming these limitations to improve therapeutic efficacy.
Purpose of the Study:
- To review and analyze current strategies for optimizing mesenchymal stem cell (MSC) therapy in tendon-bone healing.
- To evaluate the advantages, disadvantages, and mechanisms of various optimization approaches.
- To provide insights for future research and clinical translation of MSC-based therapies.
Main Methods:
- Literature review of recent advancements in MSC-based therapies for tendon-bone healing.
- Analysis of combined strategies including preconditioning, biomaterial integration, gene modification, and exosome application.
- Examination of the underlying mechanisms and therapeutic outcomes of each approach.
Main Results:
- Various strategies significantly improve MSC performance in tendon-bone healing.
- Preconditioning, biomaterials, gene modification, and exosomes offer distinct benefits and address specific MSC limitations.
- Optimized MSC therapies demonstrate enhanced healing and reduced re-rupture rates in preclinical studies.
Conclusions:
- Optimized MSC therapies hold significant potential for advancing tendon-bone healing treatments.
- A combination of strategies may be necessary to fully leverage MSC potential for clinical application.
- Further research is warranted to refine these methods and facilitate translation to clinical practice.
Related Concept Videos
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K


